RAPZX
Price
$10.43
Change
-$0.08 (-0.76%)
Updated
Feb 21 closing price
Net Assets
1.11B
RIRAX
Price
$72.54
Change
-$0.25 (-0.34%)
Updated
Feb 21 closing price
Net Assets
110.16B
Ad is loading...

RAPZX vs RIRAX

Header iconRAPZX vs RIRAX Comparison
Open Charts RAPZX vs RIRAXBanner chart's image
Cohen & Steers Real Assets Z
Price$10.43
Change-$0.08 (-0.76%)
VolumeN/A
Net Assets1.11B
American Funds Capital Income Bldr R1
Price$72.54
Change-$0.25 (-0.34%)
VolumeN/A
Net Assets110.16B
RAPZX vs RIRAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RAPZX vs. RIRAX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RAPZX is a StrongBuy and RIRAX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RIRAX has more cash in the bank: 110B vs. RAPZX (1.11B). RAPZX (2.66) and RIRAX (2.54) have matching dividends . RAPZX was incepted earlier than RIRAX: RAPZX (13 years) vs RIRAX (23 years). RIRAX (106.00) and RAPZX (104.00) have comparable annual turnover. RAPZX has a lower initial minimum investment than RIRAX: RAPZX (0) vs RIRAX (250). RAPZX (11.77) and RIRAX (11.29) have marching annual gain over last year. RAPZX return over 5 years is better than : 34.58 vs. RIRAX (24.51).
RAPZXRIRAXRAPZX / RIRAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years23 years-
Gain YTD4.5094.97891%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.11B110B1%
Annual Yield % from dividends2.662.54105%
Returns for 1 year11.7711.29104%
Returns for 3 years8.3711.9470%
Returns for 5 years34.5824.51141%
Returns for 10 years45.4431.61144%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COGT8.00-0.09
-1.11%
Cogent Biosciences
CSL334.82-8.30
-2.42%
Carlisle Companies
TNL55.14-1.98
-3.47%
Travel + Leisure Co
MRKR1.57-0.06
-3.68%
Marker Therapeutics
SMLR47.74-4.50
-8.61%
Semler Scientific